Publikationen SOMA.CK

  • Why symptom burden in non-dialysis CKD matters.
    Shedden-Mora M, Jessen B, Huber T.
    American Journal of Kidney Diseases 2024; 84(6), 672–673. doi:10.1053/j.ajkd.2024.07.005

    Zur Publikation

    Predictors of somatic symptom persistencein patients with chronic kidney disease (SOMA.CK): study protocol for a mixed-methodscohort study.
    Shedden Mora M, Jessen B, Schmidt-Lauber C, Löwe B, Rösch M, Dannenmeyer H, Gloy J, Van den Bergh O, Huber T.
    BMJ Open 2022;12:e067821. doi:10.1136/bmjopen-2022-067821

    Zur Publikation

  • Somatic symptom disorder: a scoping review on the empirical evidence of a new diagnosis.
    Löwe B, Levenson J, Depping M, Husing P, Kohlmann S, Lehmann M, Shedden-Mora M, Toussaint A, Uhlenbusch N, Weigel A.
    PSYCHOL MED. 2021:1-17.

    Zur Publikation

    Early psychological interventions for somatic symptom disorder and functional somatic syndromes: a systematic review and meta-analysis.
    Berezowski L, Ludwig L, Martin A, Löwe B, Shedden-Mora MC.
    PSYCHOSOMATIC MEDICINE. 2021; Online ahead of print.

    Zur Publikation

    Development of the generic, multidimensional Treatment Expectation Questionnaire (TEX-Q) through systematic literature review, expert surveys and qualitative interviews.
    Alberts J, Löwe B, Glahn MA, Petrie KJ, Laferton J, Nestoriuc Y, Shedden-Mora MC.
    BMJ OPEN. 2020;10:e036169.

    Zur Publikation

    SARS-CoV-2-renal tropism is associated with disease severity and acute kidney injury.
    Braun F, Luetgehetmann M, Pferfferle S, Wong M, Carsten A, Lindenmeyer M, Noerz, D, Heinrich F, Meißner K, …, Huber TB.
    LANCET. 2020: August 17.

    Zur Publikation

    Multiorgan and Renal Tropism of SARS-CoV-2.
    Puelles VG, Lütgehetmann M, Lindenmeyer MT, Sperhake JP, Wong MN, Allweiss L, Chilla S, Heinemann A, Wanner N, …, Huber TB.
    N ENGL J MED. 2020: May 13.

    Zur Publikation

    Stepped, collaborative, coordinated care for somatic symptom and related disorders (Sofu-Net) - A mixed-methods evaluation among health care professionals.
    Shedden-Mora MC, Kuby A, Tönnies J, Piontek K, Löwe B.
    ZEITSCHRIFT FÜR PSYCHOLOGIE. 2020;228(2):119-29.

    Zur Publikation

    Optimizing expectations about cancer treatment: Results of the randomized controlled PSY-BREAST trial.
    Shedden-Mora MC, Pan Y, Heisig SR, Blanckenburg Pv, Rief W, Witzel I, Albert U-S, Nestoriuc Y. CLINICAL PSYCHOLOGY IN EUROPE. 2020;2(1):e2695.

    Zur Publikation

    ARP3 Controls the Podocyte Architecture at the Kidney Filtration Barrier.
    Schell C, Sabass B, Helmstaedter M, Geist F, Abed A, Yasuda-Yamahara M, Sigle A, Maier JI, Grahammer F, …, Huber TB.
    DEV CELL. 2018:47(6):741-757.e8.

    Zur Publikation

    Patients’ expectations regarding medical treatment: a critical review of concepts and their assessment.
    Laferton JAC, Kube T, Salzmann S, Auer CJ, Shedden-Mora MC.
    FRONT PSYCHOL. 2017;8(233).

    Zur Publikation

    Effectiveness of a stepped, collaborative, and coordinated health care network for somatoform disorders (Sofu-Net): A controlled cluster cohort study.
    Löwe B, Lau K, Daubmann A, Härter M, Wegscheider K, König H-H, Shedden-Mora MC.
    PSYCHOSOM MED. 2017;79(9):1016-24.

    Zur Publikation

    The FERM protein EPB41L5 regulates actomyosin contractility and focal adhesion formation to maintain the kidney filtration barrier.
    Schell C, Rogg M, Suhm M, Helmstädter M, Sellung D, Yasuda-Yamahara M, Kretz O, Kättner V, Suleiman H, …, Huber TB.
    PROC NATL ACAD SCI USA 2017:114(23):E4621-E4630.

    Zur Publikation

    mTORC2 critically regulates renal potassium handling.
    Grahammer F, Nesterov V, Ahmed A, Steinhardt F, Sandner L, Arnold F, Cordts T, Negrea S, Bertog M, …, Huber TB.
    J CLIN INVEST. 2016;126(5):1773-82.

    Zur Publikation

  • Symptom perception in chronic kidney disease – an expert survey among nephrologists (SOMA.CK study)
    Jessen B, Schmidt-Lauber C, Huber T, Löwe B, Shedden Mora M.
    European Association of Psychosomatic Medicine, 12.-15. Juni 2024, Lausanne.
    [Poster]

    Do patients with a chronic kidney disease perceive more symptoms after negative affect induction? An experimental study.
    Jessen B, Schmidt-Lauber C, Huber T, Löwe L, Shedden Mora M.
    European Association of Psychosomatic Medicine, 15.-17. Juni 2023, Wroclaw.
    [Vortrag, 16. Juni 2023]

    Symptomwahrnehmung nach negativer Affektinduktion bei Patient:innen mit chronischer Nierenerkrankung - eine experimentelle Studie
    Jessen B, Schmidt-Lauber C, Huber TB, Löwe B, Shedden Mora M.
    Deutscher Psychotherapie Kongress, 10.-13. Mai 2023, Berlin.
    [Poster]

    Prädiktoren für die Persistenz somatischer Symptome bei Patient:innen mit chronischer Nierenerkrankung: SOMACROSS Projekt 3
    Shedden Mora M, Jessen B, Schmidt-Lauber C, Huber T.
    Deutscher Kongress für Psychosomatische Medizin und Psychotherapie, 22.-24. Juni 2022, Berlin.
    [Vortrag, 23. Juni 2022]

    Predictors of Somatic Symptom Persistence in Patients with Chronic Kidney Disease (SOMA.CK). Project 3 of the SOMACROSS research unit
    Shedden Mora M, Jessen B, Schmidt-Lauber C, Löwe B, Huber T
    European Association of Psychosomatic Medicine, 08.-11. Juni 2022, Wien.
    [Vortrag, 11. Juni 2022]